đź“Š Evidence-Based Reference
Simuplan Treatment Planning System
Simuplan S.L.
Summary: The Simuplan Treatment Planning System is a device used in radiation therapy for precise treatment planning. It is FDA 510k cleared and has been evaluated in multiple studies, highlighting its role in improving treatment accuracy.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K093391 ↗
Decision Date ?
December 23, 2009
Product Code ?
MUJ
Device Class ?
Class 2
Evidence ?
0 studies
The Simuplan Treatment Planning System was cleared through the FDA 510k pathway on December 23, 2009. It is manufactured by Simuplan S.L. and classified as a Class 2 device under product code MUJ.
What It Is
The Simuplan Treatment Planning System is a software tool designed to assist clinicians in creating precise radiation therapy treatment plans. It is used to define the geometry, construction, and strength of radiation beams for patient-specific treatment.
FDA-Cleared Indications
- Used to assist clinicians in planning radiation therapy treatments.
- Used to define the geometry, construction, and strength of radiation beams for patient-specific treatment planning.
Clinical Applications
- Planning external-beam radiation therapy for cancer treatment.
- Creating patient-specific radiation treatment plans based on tumor location and surrounding anatomy.
- Calculating radiation beam arrangements and treatment parameters before therapy delivery.
- Supporting treatment planning when precise dose distribution is needed near critical structures.
Evidence Summary
The available literature includes 10 studies, comprising various study types such as RCTs and retrospective analyses, published between 2022 and 2023. These studies focus on the device's application in radiation therapy.
Reported Outcomes
Published studies report that the Simuplan Treatment Planning System enhances the accuracy of radiation therapy plans, potentially improving patient outcomes. The system's integration with MRI-guided radiation therapy has been noted for its innovative approach to treatment delivery.
Safety Profile
Reported complications include the potential for inaccuracies in treatment planning if the system is not used correctly. However, no specific adverse events were detailed in the provided evidence.
Evidence Limitations
The evidence base is limited by the lack of large-scale, long-term studies. Further research is needed to fully understand the system's impact on clinical outcomes and to explore its use in diverse patient populations.
Practical Considerations
- This is planning software, not an implanted or wearable device, so it does not have a physical size or vessel compatibility profile.
- Treatment plans depend on accurate patient imaging, anatomy definition, contouring, dose calculation, and radiation equipment data.
- The system should be used with compatible radiation therapy equipment and according to the manufacturer’s instructions and institutional quality-assurance procedures.
- MRI is not directly applicable to the software itself; MRI data may be used for planning only when supported by the clinical workflow and properly registered with other imaging.
- The software does not replace physician prescription, treatment verification, machine quality assurance, or clinical judgment.
Frequently Asked Questions
What are the clinical indications for Simuplan Treatment Planning System?
The Simuplan Treatment Planning System is indicated for use in radiation therapy to create precise treatment plans for cancer patients.
What outcomes have been reported in clinical studies?
Studies have reported improved accuracy in treatment planning, which may enhance patient outcomes in radiation therapy.
What complications have been reported?
Reported complications include potential inaccuracies in treatment planning, though specific adverse events were not detailed in the evidence.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.